MLchartDataset catalogue

Methyl bacteriopurpurinimide

Term · Oncology and biomedicine · MLC-T-ONC-015132

A brain-penetrant bacteriochlorin analog and photosensitizer, with potential imaging and antineoplastic activities upon fluorescence imaging and fluorescence-guided photodynamic therapy (PDT) respectively. Upon administration, methyl bacteriopurpurinimide crosses the blood brain barrier (BBB) and is taken up by tumor cells. Upon clinical near-infrared (NIR) imaging, the tumor cells can be detected which allows for visualization of the tumor. Upon NIR PDT, the tumor cells are killed.

Table 1. Record
IdentifierMLC-T-ONC-015132
FieldOncology and biomedicine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-015132",
  "term": "Methyl bacteriopurpurinimide",
  "field": "Oncology and biomedicine",
  "definition": "A brain-penetrant bacteriochlorin analog and photosensitizer, with potential imaging and antineoplastic activities upon fluorescence imaging and fluorescence-guided photodynamic therapy (PDT) respectively. Upon administration, methyl bacteriopurpurinimide crosses the blood brain barrier (BBB) and is taken up by tumor cells. Upon clinical near-infrared (NIR) imaging, the tumor cells can be detected which allows for visualization of the tumor. Upon NIR PDT, the tumor cells are killed.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/methyl-bacteriopurpurinimide/"
}

Record 10,945 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.